We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$10.9B
AUM Growth
+$1.02B
Cap. Flow
+$745M
Cap. Flow %
6.83%
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
568
Reduced
596
Closed
1,134

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Healthcare 9.21%
3 Consumer Discretionary 8.28%
4 Industrials 6.28%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCCU
1626
DELISTED
Roth CH Acquisition II Co. Unit
ROCCU
$582K 0.01%
54,812
+5,911
+12% +$63.7K
ALEX
1627
DELISTED
Alexander & Baldwin
ALEX
$580K 0.01%
31,678
+12,916
+69% +$238K
MDB icon
1628
PUT
MongoDB
MDB
$30.3B
$578K 0.01%
+1,600
New +$495K
KRA
1629
DELISTED
Kraton Corporation
KRA
$577K 0.01%
+17,899
New +$632K
PVLA
1630
Palvella Therapeutics
PVLA
$2.22B
$576K 0.01%
+1,881
New +$412K
PV.U
1631
DELISTED
Primavera Capital Acquisition Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
PV.U
$576K 0.01%
56,619
-246
-0.4% -$2.51K
HROW icon
1632
Harrow
HROW
$1.47B
$575K 0.01%
+61,934
New +$528K
PBF icon
1633
PBF Energy
PBF
$7.25B
$575K 0.01%
37,618
-7,810
-17% -$121K
LEAP.U
1634
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$574K 0.01%
51,700
XENT
1635
DELISTED
Intersect ENT, Inc
XENT
$573K 0.01%
33,576
+23,489
+233% +$440K
OCUL icon
1636
Ocular Therapeutix
OCUL
$1.87B
$572K 0.01%
+40,405
New +$614K
JBTM
1637
JBT Marel
JBTM
$6.35B
$572K 0.01%
4,016
-613
-13% -$85.5K
NXDR
1638
Nextdoor Holdings
NXDR
$934M
$571K 0.01%
57,687
+20,796
+56% +$210K
KN icon
1639
Knowles
KN
$3.38B
$571K 0.01%
+28,959
New +$590K
PAHC icon
1640
Phibro Animal Health
PAHC
$1.46B
$571K 0.01%
+19,785
New +$535K
BSRR icon
1641
Sierra Bancorp
BSRR
$528M
$570K 0.01%
22,416
+2,890
+15% +$78.1K
CMLTU
1642
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
$570K 0.01%
+52,118
New +$562K
FOREU
1643
DELISTED
Foresight Acquisition Corp. Units
FOREU
$570K 0.01%
55,569
CMCT
1644
Creative Media & Community Trust
CMCT
$13.2M
$569K 0.01%
+3
New +$803K
PMGMU
1645
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$569K 0.01%
57,088
RAPT
1646
DELISTED
RAPT Therapeutics
RAPT
$568K 0.01%
2,236
-426
-16% -$79.6K
ALTUU
1647
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$568K 0.01%
55,861
+1,524
+3% +$15.8K
TIP icon
1648
iShares TIPS Bond ETF
TIP
$14.5B
$567K 0.01%
4,432
-12,111
-73% -$1.54M
SGOL icon
1649
abrdn Physical Gold Shares ETF
SGOL
$7.25B
$566K 0.01%
33,525
ERY icon
1650
Direxion Daily Energy Bear 2X ETF
ERY
$42.2M
$562K 0.01%
4,027
+1,578
+64% +$252K

Similar funds

HRT Financial's Q2 2021 Portfolio in Review

As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HRT Financial deployed $745M of net new capital in Q2 2021, opening 1,275 new positions and adding to 568 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.

  • HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
  • HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
  • HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
  • HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
  • HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
  • HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
  • HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.